24/7 Patient Assistance: 760-405-8205

Thierry M. Jahan, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Peritoneal Mesothelioma Pleural Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Thierry Jahan received his medical degree from the George Washington University School of Medicine. His residency was split between Cedars-Sinai Medical Center and UCLA, while he completed his fellowship at the University of California in San Francisco. Dr. Thierry Jahan is currently a lung cancer specialist at the UCSF Medical Center at Mount Zion, focusing on cancers such as mesothelioma. Dr. Jahan conducts studies towards more efficient treatment methods for mesothelioma and other related affections of the lungs, with numerous awards and publications detailing his findings.


  • Education & Training

    dept_icon

    Columbia University - 1983

    Education

    dept_icon

    George Washington University School of Medicine - 1987

    Medical School

    dept_icon

    Cedars-Sinai Medical Center/UCLA

    Residency

    dept_icon

    Sinai Medical Center/ UCLA Division of General Internal Medicine; University of California at San Francisco

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    UCSF Medical Center at Mount Zion

    Languages: English/Spanish

    (888) 689-8273

    1600 Divisadero St

    San Francisco, California 94115

    Read More
  • Publications & Memberships

    Dr. Thierry M. Jahan has contributed to 4 publications.

    208O_PR: CRS-207 with chemotherapy (chemo) in malignant pleural mesothelioma (MPM)

    Jahan T, Hassan R, Alley E, Kindler H, Antonia S, Whiting C, Coussens L, Murphy AL, Thomas A, Brockstedt DG. Results from a phase 1b trial. J Thorac Oncol.

    See more >>

    A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.

    Thomas S, Aggarwal R, Jahan T, Ryan C, Troung T, Cripps AM, Raha P, Thurn KT, Chen S, Grabowsky JA, Park J, Hwang J, Daud A, Munster PN. Ann Onc

    See more >>

    Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma.

    Tinkle CL, Weinberg V, Braunstein SE, Wustrack R, Horvai A, Jahan T, O\'Donnell RJ, Gottschalk AR.

    See more >>

    Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity.

    Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom SS. Am J Clin Oncol.

    See more >>

    Memberships

    American College of Physicians

    American Society of Clinical Oncology

    Association of Northern California Oncologist

    International Association for the Study of Lung Cancer

Verified Patient Reviews

Rate This Doctor

February 10, 2016

by Mike R.

Wait Time

Staff

Helpfulness

Knowledge

“Most of the time you have to wait for your appointment, but you have to understand that he spends as much time as you need when you are his patient. You are his priority and no one will ever rush you. He answered to all of my questions and made me feel comfortable with my treatment which is very important when someone deals with cancer. So you might have to wait, because he takes care of all of his patients.”